Teva, AbbVie ink opioid settlements worth nearly $330M with Floridanews2022-03-30T18:47:39+00:00March 30th, 2022|Fierce Pharma|
In a year of big growth for AbbVie, CEO Richard Gonzalez scored $24M pay packagenews2022-03-30T17:27:53+00:00March 30th, 2022|Fierce Pharma|
Roche says hola to Hispanic, Latinx multiple sclerosis communitiesnews2022-03-30T15:55:04+00:00March 30th, 2022|Fierce Pharma|
Sanofi CEO Hudson’s 2021 pay dips no thanks to lagging vaccine sales in US, Chinanews2022-03-30T15:34:51+00:00March 30th, 2022|Fierce Pharma|
As Lilly, Innovent hit FDA rebuff, another China-made PD-1 cancer drug faces possible delaynews2022-03-30T14:06:29+00:00March 30th, 2022|Fierce Pharma|
UPDATED: Merck cuts 143 jobs at Acceleron right on heels of $11.5B buyoutnews2022-03-30T13:55:57+00:00March 30th, 2022|Fierce Pharma|
Pfizer mRNA partner BioNTech reaped €19 billion last year but warns of lower prices in 2022news2022-03-30T13:51:00+00:00March 30th, 2022|Fierce Pharma|
Pfizer mRNA partner BioNTech reaped €19B last year but warns of lower prices in 2022news2022-03-30T13:51:00+00:00March 30th, 2022|Fierce Pharma|
Teva recalls one lot of leukemia med after finding particulates in vialnews2022-03-30T12:36:17+00:00March 30th, 2022|Fierce Pharma|
Novo Nordisk snags high-dose Ozempic approval, turning up the heat on Lilly’s Trulicitynews2022-03-30T11:06:48+00:00March 30th, 2022|Fierce Pharma|
